Cleared Traditional

K081033 - MIROXI

K081033 is an FDA 510(k) clearance for MIROXI, manufactured by Mir Medical Intl. Research Srl. The device is a Class 2 Anesthesiology device with product code DQA cleared through the Traditional 510(k) pathway after a 279-day FDA review.

K081033 · Mir Medical Intl. Research Srl · Anesthesiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jan 2009
Decision
279d
Days
Class 2
Risk

K081033 is an FDA 510(k) clearance for the MIROXI. Classified as Oximeter (product code DQA), Class II - Special Controls.

Submitted by Mir Medical Intl. Research Srl (Roma, IT). The FDA issued a Cleared decision on January 15, 2009 after a review of 279 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K081033

510(k) Number K081033 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 11, 2008
Decision Date January 15, 2009
Days to Decision 279 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
139d slower than avg
Panel avg: 140d · This submission: 279d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQA Device Classification - Class 2, Special Controls

Product Code DQA Oximeter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - DQA Oximeter

All 687
Devices cleared under the same product code (DQA) and FDA review panel - the closest regulatory comparables to K081033.
QUANTA PULSE OXIMETER, MODEL: PULSE LINK 1000 OR QH100
K083079 · Quanta Computer, Inc. · Mar 2009
M-50 SERIES SPO2 SENSOR
K082487 · Beijing Choice Electronic Technololgy Co., Ltd. · Mar 2009
CAPNOSTREAM20 WITH INTEGRATED PULMONARY INDEX
K082268 · Oridion Capnography, Inc. · Feb 2009
G1B PULSE OXIMETER
K082789 · General Meditech, Inc. · Jan 2009
REUSABLE OHMEDA (U410-02), DATEX (U410-09) COMPATABLE ADULT FINGER CLIP SENSOR, PHILLIPS ADULT SOFT TIP SENSOR(U403S-91)
K082546 · Unimed Medical Supplies, Inc. · Dec 2008
INFINITY NELLCOR OXIMAX SMARTPOD, MODEL MS23997
K082888 · Draeger Medical Systems, Inc. · Nov 2008